panitumumab
Amgen,Takeda
['colorectal', 'triplet', 'triplete', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'panitumumab', 'rectal']
 #asco22 simultaneous pub in #jco by et al upfront mfolfoxiri + panitumumab vs folfox + panitumumab for pts with ras/braf wild-type metastatic #colorectalcancer: the phase iii triplete study by gono #crcsm #mcrc 
@ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.